Rapport Therapeutics (NASDAQ:RAPP) Shares Down 6.5%
Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) shares were down 6.5% during mid-day trading on Wednesday . The company traded as low as $23.93 and last traded at $24.18. Approximately 90,930 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 242,660 shares. The stock had previously closed at […]
More Stories
Analysts Set Alumis Inc. (NASDAQ:ALMS) Price Target at $27.50
Shares of Alumis Inc. (NASDAQ:ALMS – Get Free Report) have received an average recommendation of “Buy” from the eight analysts...
First Interstate BancSystem, Inc. (NASDAQ:FIBK) Receives $32.50 Consensus Target Price from Brokerages
Shares of First Interstate BancSystem, Inc. (NASDAQ:FIBK – Get Free Report) have earned an average recommendation of “Hold” from the...
StockNews.com Upgrades Thomson Reuters (NYSE:TRI) to “Hold”
StockNews.com upgraded shares of Thomson Reuters (NYSE:TRI – Free Report) (TSE:TRI) from a sell rating to a hold rating in...
Oak Woods Acquisition Co. (NASDAQ:OAKUW) Sees Significant Decline in Short Interest
Oak Woods Acquisition Co. (NASDAQ:OAKUW – Get Free Report) was the recipient of a significant drop in short interest in...
PIMCO Municipal Income Fund III (NYSE:PMX) Short Interest Down 24.4% in October
PIMCO Municipal Income Fund III (NYSE:PMX – Get Free Report) was the recipient of a large decrease in short interest...
Enstar Group Limited (NASDAQ:ESGRO) Short Interest Update
Enstar Group Limited (NASDAQ:ESGRO – Get Free Report) saw a large drop in short interest during the month of October....